Fuji Medical Systems USA and Olicon Imaging Systems this month signed a nonexclusive licensing and product distribution agreement. The deal enables Fuji, which has specialized in the development of computed radiography systems, to sell turnkey PACS
Fuji Medical Systems USA and Olicon Imaging Systems this month signed a nonexclusive licensing and product distribution agreement. The deal enables Fuji, which has specialized in the development of computed radiography systems, to sell turnkey PACS solutions to hospitals.
Under the terms of the agreement, Fuji will distribute Olicon's PACS products when customers desire a single-vendor solution for PACS and CR, according to Clay Larsen, managing director of marketing for Stamford, CT-based Fuji. Fuji can now directly offer its CR customers PACS products, whereas in the past, it had to refer them to another vendor, Larsen said.
San Clemente, CA-based Olicon, on the other hand, will license Fuji's CR image processing algorithms for use on Olicon's workstations, making them more suited for primary CR reading by radiologists, according to Dick Paulsen, Olicon's CEO. Olicon also believes the agreement will give the company an advantage in marketing its products to Fuji CR customers who are interested in upgrading to PACS.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.